http://archive.fast-edgar.com/20230609/AJZ2P22COM22PT52222H2ZZ2MPLDU22II252
Filed on: June 9, 2023
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
☒
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive... (continue reading...)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2023
Commission File Number: 001-33107
CANADIAN SOLAR INC.
545 Speedvale Avenue West, Guelph,
Ontario, Canada N1K 1E6
(Address of principal executive office)
Indicate by check mark... (continue reading...)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2023
Commission File Number: 001-33107
CANADIAN SOLAR INC.
545 Speedvale Avenue West, Guelph,
Ontario, Canada N1K 1E6
(Address of principal executive office)
Indicate by check mark... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Vor Biopharma Inc. For: Jun 09
-
Form N-CSR NB Private Markets Fund For: Mar 31
-
Form 8-K Distribution Solutions For: Jun 08
-
Form N-CSR NB Private Markets Fund For: Mar 31
-
Form 8-K Bloom Energy Corp For: Jun 08
-
Form D/A AB Financial Services
-
Form 8-K RECURSION PHARMACEUTICAL For: Jun 09
-
Form 424B5 RECURSION PHARMACEUTICAL
-
Form 6-K GRANITE REIT INC. For: Jun 08 Filed by: GRANITE REAL ESTATE INVESTMENT TRUST
-
Form 6-K NIO Inc. For: Jun 09
-
Form 4 Garrett Motion Inc. For: Jun 06 Filed by: Atlas OCM Holdings, LLC
-
Form D Anthropic - Incepto AGI
-
Form 8-K Centessa Pharmaceuticals For: Jun 09
-
Form D/A Capstone Convex Portfoli
-
Form 8-K CRISPR Therapeutics AG For: Jun 08
-
Form 6-K CHINA LIFE INSURANCE CO For: Jun 09
-
Form D GAI C - AV Master LLC
-
Form 8-K Praxis Precision Medicin For: Jun 09
-
Form D/A V3 Realty Partners Offsh
-
Form 144 MYOMO, INC. Filed by: Kovelman Harry
-
Form S-3ASR TYSON FOODS, INC.
-
Form 6-K Renalytix plc For: Jun 09
-
Form 6-K Vox Royalty Corp. For: Jun 09
-
Form 6-K QuantaSing Group Ltd For: Jun 09
-
Form S-8 NIO Inc.
-
Form D/A V3 Realty Partners, L.P.
-
Form 6-K NatWest Group plc For: Jun 09
-
Form D/A Solus Series Domestic
-
Form D GF SPV 4 - Growth Factor
-
Form FWP MAIA Biotechnology, Inc. Filed by: MAIA Biotechnology, Inc.
-
Form D/A Honeycomb Offshore Fund
-
Form 6-K Endava plc For: Jun 01
-
Form 6-K Waterdrop Inc. For: Jun 09
-
Form 6-K ASTRAZENECA PLC For: Jun 09
-
Form 6-K TAIWAN SEMICONDUCTOR For: May 31
-
Form S-8 Tuniu Corp
-
Form 6-K Tuniu Corp For: Jun 09
-
Form D/A Honeycomb Partners LP
-
Form 6-K CHEMICAL & MINING CO OF For: Jun 08
-
Form 8-K Philip Morris Internatio For: Jun 09
-
Form 10-K Nextracker Inc. For: Mar 31
-
Form D/A Keynes Dynamic Beta Stra
-
Form D/A Keynes Leveraged Quantit
-
Form 6-K ASTRAZENECA PLC For: Jun 09
-
Form D/A MCI PREFERRED INCOME
-
Form 10-Q GLOBAL LEADERS CORP For: Apr 30
-
Form 4 Garrett Motion Inc. For: Jun 06 Filed by: Oaktree Value Opportunities Fund GP Ltd.
-
Form 8-K Kennedy-Wilson Holdings, For: Jun 08
-
Form S-1/A Maison Solutions Inc.
-
Form D/A GEM Realty Securities
